| [1] |
LI Rui, CHUAN Jintao, ZHANG Peilian.
Advance of deucravacitinib in the treatment of immune-mediated dermatoses
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(6): 470-474.
|
| [2] |
HE Lucen, ZHOU Guizhi, ZHANG Fan, LIU Hong.
Tofacitinib in the treatment of acquired reactive perforating collagenosis: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 348-352.
|
| [3] |
ZHAO Xiaoyu, XUE Xiaotong, ZHANG Furen.
Successful treatment of erythema nodosum with tofacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 371-372.
|
| [4] |
JIANG Xiaoxue, CHEN Ruolin, WANG Yuxi, SHI Zhiyuan, LIU Xinyi, CAO Yan.
Advances in targeted therapy for acral vitiligo
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 373-377.
|
| [5] |
LI Xiaoxian, CAO Nan, CHEN Xi, LIU Guoyan.
Update of small molecule drugs and targeted therapies for moderate-to-severe alopecia areata
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(4): 305-310.
|
| [6] |
LIU Mingyue, TAN Shuhui, ZHANG Zhe, NIE Zhenhua.
Update of the treatment for bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(7): 538-542.
|
| [7] |
YU Wanlong, BAI Fan, YANG Yinan, LI Shuangshuang, XU Yabo, CHANG Feiyu, LEI Mingjun.
Generalised pustular psoriasis with alopecia treated with deucravacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 450-452.
|
| [8] |
YUAN Mingzhu, LI Ruyi, SUN Yi, ZHANG Wen.
Severe alopecia areata unresponsive to baricitinib susessfully treated with upadacitinib: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 283-287.
|
| [9] |
TONG Zequn, ZENG Xueting, HUNAG Fuchen, JI Chao.
Rapid improvement of chronic actinic dermatitis with abrocitinib: three cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 811-815.
|
| [10] |
YAN Yuanyuan, ZHAO Yanxia, CHENG Yu.
Update of Janus kinase inhibitors in the treatment of vitiligo
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 519-523.
|
| [11] |
CUI Yinling, XU Fanli, CAO Shan, XUE Xiaotong, ZHAO Qing, LIU Yongxia, LIU Hong, ZHANG Furen.
Abrocitinib in the treatment of cutaneous lichen planus: two cases and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 412-415.
|
| [12] |
JIAO Yuzhu, YANG Qing.
Update of treatment of pyoderma gangrenosum
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
|
| [13] |
XU Yang, ZHAN Weisheng, ZHAO Juhua.
Efficacy and safety of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis: a meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 89-94.
|
| [14] |
YUAN Jinxiang, WANG Tianxue, ZHANG Junling.
Research progress of deucravacitinib in the treatment of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 693-697.
|
| [15] |
WANG Tianzi, LU Jiliang, LIU Yongxia, TIAN Hongqing.
Three cases with palmoplantar pustulosis successfully treated by tofacitinib
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 397-402.
|